7 Spam-Free Article(s) Found
Sort:
Date
Filter:
7d
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
SNY Sanofi $43.75 $109.14B N/A
Article Searches
Sanofi Plans to Spin Off Drug Ingredient Business https://www.fool.com/investing/2020/02/24/sanofi-plans-to-spin-off-drug-ingredient-business.aspx?source=iedfolrf0000001 Feb 24, 2020 - The resulting spinoff would become the world's second largest drug ingredient producer.
Emergent (EBS) Earnings Miss in Q4, Revenues Beat Estimates http://www.zacks.com/stock/news/777571/emergent-ebs-earnings-miss-in-q4-revenues-beat-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-777571 Feb 21, 2020 - Emergent's (EBS) earnings lag estimates in Q4 while revenues surpass the mark.
Pharma Stock Roundup: AZN Reports Q4 Results, NVS, PFE Drugs Get EU Approval http://www.zacks.com/stock/news/777121/pharma-stock-roundup-azn-reports-q4-results-nvs-pfe-drugs-get-eu-approval?cid=CS-ZC-FT-analyst_blog|stock_roundup-777121 Feb 21, 2020 - AstraZeneca's (AZN) Q4 results were disappointing. European Commission approves Novartis (NVS) and Pfizer's (PFE) new drugs.
What's in the Cards for Amarin (AMRN) This Earnings Season? http://www.zacks.com/stock/news/775151/whats-in-the-cards-for-amarin-amrn-this-earnings-season?cid=CS-ZC-FT-analyst_blog|earnings_preview-775151 Feb 20, 2020 - Amarin's (AMRN) fourth-quarter results are likely to reflect strong demand for its cardiovascular drug, Vascepa.
Top Research Reports for Facebook, Netflix & NextEra Energy http://www.zacks.com/research-daily/773289/top-research-reports-for-facebook-netflix-nextera-energy?cid=CS-ZC-FT-research_daily-773289 Feb 19, 2020 - Top Research Reports for Facebook, Netflix & NextEra Energy
Sanofi, J&J Join Forces With BARDA for Coronavirus Vaccine http://www.zacks.com/stock/news/773194/sanofi-jj-join-forces-with-barda-for-coronavirus-vaccine?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-773194 Feb 19, 2020 - Sanofi (SNY) and J&J (JNJ) sign deals with BARDA, part of U.S. Department of Health and Human Services, for accelerated development of a vaccine for the newly found coronavirus.
Sanofi Gets Backing From U.S. Government to Develop a COVID-19 Vaccine https://www.fool.com/investing/2020/02/18/sanofi-us-government-covid-19-vaccine.aspx?source=iedfolrf0000001 Feb 18, 2020 - The French drugmaker joins a host of other companies trying to develop vaccines and treatments for the coronavirus.

Pages: 1

Page 1